(Q36830277)

16 August 2017

1 reference

title

The impact of diabetes on heart failure: opportunities for intervention (English)

1 reference

16 August 2017

Hadi N Skouri

1

1 reference

16 August 2017

W H Wilson Tang

series ordinal

2

1 reference

16 August 2017

publication date

1 June 2007

1 reference

Current heart failure reports

16 August 2017

published in

1 reference

16 August 2017

volume

4

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

70-77

1 reference

Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart

16 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11897-007-0003-8

Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus

21 January 2018

1 reference

12 December 2020

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

12 December 2020

The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group

1 reference

12 December 2020

Direct evidence that perhexiline modifies myocardial substrate utilization from fatty acids to lactate

1 reference

12 December 2020

Effects of trimetazidine on left ventricular function in patients with type 2 diabetes and heart failure

1 reference

12 December 2020

Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment

1 reference

12 December 2020

Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction

1 reference

12 December 2020

Time to address the cardiac metabolic "triple whammy" ischemic heart failure in diabetic patients

1 reference

12 December 2020

Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure

1 reference

12 December 2020

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications

1 reference

12 December 2020

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Inf

1 reference

12 December 2020

Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease.

1 reference

12 December 2020

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

12 December 2020

Initial experience with GLP-1 treatment on metabolic control and myocardial function in patients with type 2 diabetes mellitus and heart failure

1 reference

12 December 2020

Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

1 reference

12 December 2020

Regulation of energy substrate metabolism in the diabetic heart

1 reference

12 December 2020

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

1 reference

12 December 2020

Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease

1 reference

12 December 2020

Myocardial substrate metabolism in the normal and failing heart

1 reference

12 December 2020

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials

1 reference

12 December 2020

Role of changes in cardiac metabolism in development of diabetic cardiomyopathy

1 reference

12 December 2020

Free fatty acids repress the GLUT4 gene expression in cardiac muscle via novel response elements

1 reference

12 December 2020

Uncoupling proteins in human heart

1 reference

12 December 2020

Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors

1 reference

12 December 2020

Role of diabetes in congestive heart failure: the Framingham study

1 reference

12 December 2020

The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy

1 reference

12 December 2020

Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts.

1 reference

12 December 2020

Impact of diabetes mellitus on long-term survival in patients with congestive heart failure.

1 reference

12 December 2020

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.

1 reference

12 December 2020

Impact of diabetes on cardiac structure and function: the strong heart study

1 reference

12 December 2020

Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group.

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk In Communities study, 1987-1998.

1 reference

12 December 2020

A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure

1 reference

12 December 2020

Metabolic syndrome and the risk of cardiovascular disease in older adults

1 reference

12 December 2020

Functional class in patients with heart failure is associated with the development of diabetes

1 reference

12 December 2020

First clinical trial with etomoxir in patients with chronic congestive heart failure

1 reference

12 December 2020

Association of glycogenolysis with cardiac sarcoplasmic recticulum: II. Effect of glycogen depletion, deoxycholate solubilization and cardiac ischemia: Evidence for a phosphorylase kinase membrane complex

1 reference

12 December 2020

Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database

1 reference

12 December 2020

Metabolic syndrome and risk for heart failure in middle-aged men.

1 reference

12 December 2020

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study

1 reference

12 December 2020

Regeneration of the heart in diabetes by selective copper chelation

1 reference

12 December 2020

Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry

1 reference

12 December 2020

Diabetes in heart failure: prevalence and impact on outcome in the population

1 reference

12 December 2020

Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy

1 reference

12 December 2020

Oxidative stress and functional deficit in diabetic cardiomyopathy

1 reference

12 December 2020

Glycemic control and treatment patterns in patients with heart failure

1 reference

12 December 2020

Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy

1 reference

12 December 2020

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

1 reference

12 December 2020

Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions

1 reference

12 December 2020

10.1007/S11897-007-0003-8

Identifiers

DOI

1 reference

16 August 2017

1 reference